181 research outputs found

    False-positive radioiodine whole-body scan due to a renal cyst

    Get PDF
    Patients affected by differentiated thyroid cancer are treated surgically and by ablative radioiodine therapy. A post-therapy whole-body scan allows detection of thyroid remnants or local and distant metastases, although false-positive findings may be observed. We report a case of a 75-year-old woman with follicular thyroid cancer, who underwent ablative radioiodine treatment. On post-therapy wholebody scan, abnormal uptake in the left upper abdomen was found, although stimulated thyroglobulin level was not suggestive for distant metastases of differentiated thyroid carcinoma. Additional SPECT/CT acquisition revealed focal 131I uptake located at the posterolateral wall of the left kidney corresponding to a round lesion 47 mm in maximal diameter. In order to verify this finding abdominal ultrasound and abdominal contrast-enhanced CT were performed, confirming multiple renal cysts in the left kidney; the largest one was the site of abnormal radioiodine accumulation. Despite the high incidence of renal cysts, especially in the elderly, radioiodine uptake in renal cystsis extremely rare. Different hypotheses on the mechanism of radioiodine uptake in the cyst were proposed, among them active secretion by sodium-iodide symporter or other transporting proteins. We conclude that abnormal radioiodine uptake in renal cysts can be an exceptional finding mimicking a metastasis

    Does the type of a centre in which the resection of extensive tumours of the limbs and truck is performed, affect the patients’ survival?

    Get PDF
    Nowoczesna chirurgia rekonstrukcyjna opiera się na odpowiednim wykorzystaniu dostępnych metod rekonstrukcyjnych, w tym mikronaczyniowych. Zaplanowanie odpowiedniej operacji rekonstrukcyjnej daje możliwość wykonania maksymalnie szerokiej resekcji, co dodatkowo zwiększa radykalność zabiegu. Ostatnimi czasy zaznacza się tendencja do wykonywania rozległych resekcji nowotworów w ośrodkach nie dysponujących bogatym doświadczeniem w tego rodzaju procedurach. Istnieje obawa, że, z uwagi na brak możliwości wykonania jednoczasowej rekonstrukcji, zakres resekcji może być niewystarczający do uzyskania pełnej radykalności zabiegu. W oparciu o wyniki badań 71 chorych leczonych w Klinice Chirurgii Onkologicznej i Rekonstrukcyjnej w latach 2006 – 2017 z powodu rozległych zmian nowotworowych tułowia i kończyn wykazano, że chorzy leczeni pierwotnie (zabieg resekcyjny) poza Instytutem charakteryzowali się znacząco krótszym czasem przeżycia do wznowy. Powyższe wyniki stanowią głos potwierdzający zasadność przeprowadzania rozległych zabiegów resekcyjno – rekonstrukcyjnych w przypadku zaawansowanych zmian nowotworowych, w ośrodkach o bogatym doświadczeniu w tym zakresie

    Individually personalized radiotherapy vs. evidence (trials) based standards – paradigms and dilemmas

    Get PDF
    This paper opens up to discussion whether some questions, points of view, and doubts counterbalance the belief and dogmas that randomized clinical trials (mainly in radiotherapy) should be considered as the only source of guidelines to design novel therapeutic standards in radiotherapy. A number of the physics, radiotherapy, clinical radiobiology and genetic and molecular tumor’s characteristics suggest that radiotherapy protocols based on the “evidence based trials” seem to be antonymous to individually personalized therapy. The major goal of this paper is to consider and discuss whether individually personalized radiotherapy is already attainable and reliable or still remains the exception

    Classical nonintegrability of a quantum chaotic SU(3) Hamiltonian system

    Full text link
    We prove nonintegrability of a model Hamiltonian system defined on the Lie algebra su3\mathfrak{su}_3 suitable for investigation of connections between classical and quantum characteristics of chaos.Comment: 17 page

    Adjuvant radiotherapy post microvascular reconstructive surgery (MRS) for patients with locally advanced head and neck cancer – when and how?

    Get PDF
    For many decades palliation (radiotherapy, chemotherapy or symptomatic treatment) was the only therapeutic solu­tion for locally very advanced head and neck cancer. In the mid 70s, H. Buncke carried out pioneering microvascular reconstructive surgery (MRS) as a radical treatment. Since that time, the MRS has been accepted around the world as a successful radical therapy, not only for head and neck (H&N) cancers. A part of the H&N cancers need however post­-MRS radiotherapy (RT). Based on the 20 year experience of the Institute of Oncology in Gliwice with MRS (about 2500 patients), D. Bula has defined local recurrence risk factors. Dutch studies convincingly documented the prognostic value of the estimated molecular profiles of the resected margins as additional risk factors. The use of conventional 2.0 Gy/ fraction post-MRS-RT result in a high risk of the inserted reconstructive flap necrosis or rejection. Therefore, a novel IMRT­-VMAT technique with 50 Gy given in 1.5–1.6 Gy/fraction has been designed which allows to almost eliminate the flap from the irradiated volume and therefore minimizes recurrence and/or flap rejection to almost zero. The present paper shows objectively selected a cluster of patients being the candidate to post-MRS safe and effective VMAT radiotherapy

    Axillary lymph node and early breast cancer diagnostics. A case report

    Get PDF
    Understanding of the anatomy of the axillary lymph nodes is important in diagnostic and treatment procedures for breast cancer. An interesting case is presented here of breast cancer without a breast tumour. The first symptom of the disease was lymphadenopathy of the axillary region. This kind of case is extremely rare in clinical practise (one case per 1-5 years) and constitutes a great problem for specialists, since in many cases the primary neoplasm source is unknown. The anatomical and clinical implications of such a situation are discussed

    Adjuvant radiotherapy post microvascular reconstructive surgery (MRS) for patients with locally advanced head and neck cancer – when and how?

    Get PDF
    For many decades palliation (radiotherapy, chemotherapy or symptomatic treatment) was the only therapeutic solu­tion for locally very advanced head and neck cancer. In the mid 70s, H. Buncke carried out pioneering microvascular reconstructive surgery (MRS) as a radical treatment. Since that time, the MRS has been accepted around the world as a successful radical therapy, not only for head and neck (H&N) cancers. A part of the H&N cancers need however post­-MRS radiotherapy (RT). Based on the 20 year experience of the Institute of Oncology in Gliwice with MRS (about 2500 patients), D. Bula has defined local recurrence risk factors. Dutch studies convincingly documented the prognostic value of the estimated molecular profiles of the resected margins as additional risk factors. The use of conventional 2.0 Gy/ fraction post-MRS-RT result in a high risk of the inserted reconstructive flap necrosis or rejection. Therefore, a novel IMRT­-VMAT technique with 50 Gy given in 1.5–1.6 Gy/fraction has been designed which allows to almost eliminate the flap from the irradiated volume and therefore minimizes recurrence and/or flap rejection to almost zero. The present paper shows objectively selected a cluster of patients being the candidate to post-MRS safe and effective VMAT radiotherapy
    corecore